Posted inBiotechnology
Academic Cancer Trials Drive Global Advances in Patient Care
In an era dominated by rapid scientific advancement and pharmaceutical innovation, the critical role of independent academic clinical cancer trials…
Posted inBiotechnology
FDA flags concerns for AstraZeneca’s camizestrant, Truqap ahead of advisory committee meeting
The FDA has released briefing documents detailing its concerns for AstraZeneca’s cancer drugs camizestrant and Truqap ahead of an upcoming…
Posted inBiotechnology
FDA unveils plan for real-time review of clinical trial data, with AstraZeneca and Amgen already on board
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time,…
Posted inBiotechnology
26 Years of Advancing EGFR-TKIs in Non-Small Cell Lung Cancer: Breakthroughs in Clinical Use and Resistance Mechanisms
Over the past three decades, the landscape of non-small cell lung cancer (NSCLC) treatment has been profoundly transformed by the…
Posted inBiotechnology
Hasanuddin University Study Uncovers Key Insights for Enhancing Climate Resilience in Smallholder Cacao Farms
Across tropical agrarian landscapes, cacao cultivation faces mounting challenges owing to accelerating climate variability that threatens the stability of yields…
Posted inBiotechnology
Protagonist opts for $475M in Takeda payouts instead of splitting US rusfertide profits
After mulling its options for the past few months, Protagonist Therapeutics has decided to pocket $475 million from Takeda rather…
Posted inBiotechnology
Nurse-Led Orthogeriatric Care Boosts Elderly Fracture Outcomes
In the evolving landscape of geriatric healthcare, the management of osteoporotic fractures among older adults presents a persistent challenge. Recent…
Posted inBiotechnology
HIF2α Inhibitors: New Frontiers in Cancer Treatment
Hypoxia-inducible factor 2α (HIF2α), a transcription factor pivotal to cellular adaptation under low oxygen conditions, has long stood as a…
Posted inBiotechnology
CNIO Study Paves the Way for Personalized Liver Fibrosis Therapies
Liver fibrosis is a common pathological feature underlying a wide spectrum of chronic liver diseases and acts as a precursor…
Posted inBiotechnology
AbbVie dips into boiling RAS waters with $1.45B biobucks deal that could end in acquisition
After debunking earlier rumors that it was acquiring RAS superstar Revolution Medicines, AbbVie is now taking a more definitive step…